Irene Hramiak, MD, FRCPC
Dr. Hramiak is a Professor of Medicine and Chair of the Division of Endocrinology and Metabolism at the University of Western Ontario (UWO). Dr. Hramiak practices at St. Joseph’s Health Care London in London, Ontario. She has been the Medical Director of the Diabetes Education Center at St. Joseph’s Health Care since 2000 with a particular interest in diabetes and obesity.
Dr. Hramiak is currently a Principal Investigator in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, which is assessing cardiac outcomes in patients with type 2 diabetes mellitus. She is also the Principal Investigator for the JDRF Canadian Clinical Trial Network (CCTN) at UWO.
Dr. Hramiak has held peer reviewed funding from the Juvenile Diabetes Research Foundation (JDRF), Canadian Diabetes Research Foundation (CDA), and the National Institute of Health (NIH). Dr. Hramiak was also a co-investigator in the Diabetes Control and Complication Trial (DCCT) – a major outcome trial in type 1 diabetes mellitus. As a DCCT investigator, she was awarded the Charles H. Best Award for distinguished service by the American Diabetes Association (ADA) in 1993.
She has been involved in many clinical trials assessing new treatment strategies in both type 1, type 2 diabetes mellitus and obesity, including as an author of the 2007 Canadian Obesity Guidelines. Dr. Hramiak’s focus in obesity has been in risk factor management of obese patients. She serves as an external advisor to many groups and pharmaceutical companies with regards to diabetes and obesity.